The American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel created two Category I CPT codes ...

Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension The Paradise uRDN system is a first-of-its-kind ultrasound-based renal denervation (RDN) technology designed to ...

Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

PARIS, France—Two new renal denervation (RDN) systems seem to be safe and effective in patients with uncontrolled hypertension, according to presentations here at EuroPCR 2023. In the SMART trial, a ...

Please provide your email address to receive an email when new articles are posted on . For the first time in its history, the U.S. Renal Data System Annual Data Report included a chapter devoted to ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The latest edition of the United States Renal Data ...